Sandonorm
Sandonorm Uses, Dosage, Side Effects, Food Interaction and all others data.
Sandonorm (INN) is an ester prodrug for the beta blocker pindolol.
Sandonorm is a prodrug of pindolol. Pindolol is a non-selective beta-adrenergic antagonist (beta-blocker) which possesses intrinsic sympathomimetic activity (ISA) in therapeutic dosage ranges but does not possess quinidine-like membrane stabilizing activity. Pindolol impairs AV node conduction and decreases sinus rate and may also increase plasma triglycerides and decrease HDL-cholesterol levels. Pindolol is nonpolar and hydrophobic, with low to moderate lipid solubility. Pindolol has little to no intrinsic sympathomimetic activity and, unlike some other beta-adrenergic blocking agents, pindolol has little direct myocardial depressant activity and does not have an anesthetic-like membrane-stabilizing action.
| Trade Name | Sandonorm |
| Generic | Bopindolol |
| Bopindolol Other Names | Bopindolol, Bopindololum |
| Type | |
| Formula | C23H28N2O3 |
| Weight | Average: 380.48 Monoisotopic: 380.209992772 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
For the management of hypertension, edema, ventricular tachycardias, and atrial fibrillation.
How Sandonorm works
Sandonorm (as pindolol) non-selectively blocks beta-1 adrenergic receptors mainly in the heart, inhibiting the effects of epinephrine and norepinephrine resulting in a decrease in heart rate and blood pressure. By binding beta-2 receptors in the juxtaglomerular apparatus, Pindolol inhibits the production of renin, thereby inhibiting angiotensin II and aldosterone production and therefore inhibits the vasoconstriction and water retention due to angiotensin II and aldosterone, respectively.
Innovators Monograph
You find simplified version here Sandonorm
